T Mlčoch1, R Puda2, P Ješina3, M Lhotáková2, Š Štěrbová2, T Doležal1. 1. Institute of Health Economics and Technology Assessment, Prague, Czech Republic. 2. Národní sdružení PKU a jiných DMP, z.s. (National Association of Patients with PKU and Other IMD (NSPKU)), Prague, Czech Republic. 3. Institute of Inherited Metabolic Disorders, Charles University-First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
Abstract
BACKGROUND/ OBJECTIVES: Phenylketonuria (PKU) and several other inherited metabolic diseases (IMD) require a lifelong low-protein diet (LPD), otherwise they lead to many health complications. LPDs, however, carry a significant economic burden for patients and their families. The objective of this study was to explore the costs of low-protein foods (LPFs) necessary for LPD as well as dietary patterns and compliance towards an LPD. SUBJECTS/ METHODS: A detailed questionnaire was created in cooperation with National Association of PKU and other IMD (NSPKU), and consequently sent to all NSPKU members treated with an LPD (n=303). A total of 184 respondents from the Czech Republic were included in the study (174 had PKU, 10 had other IMD). RESULTS: The average daily consumption of LPF was equal to 411.7 g (PKU) and 345.6 g (other IMD), which corresponds to energy value of 5558 kJ and 4438 kJ, respectively, per patient per day. Patients mostly consumed low-protein flour (≈30% of energy intake), pasta (≈18%), basic pastry (≈15%) and sweets (≈10%). The average monthly costs of LPDs were equal to [euro ]130 (PKU) and [euro ]129 (other IMD) per patient per month. The compliance with LPD was decreasing with increasing age (P<0.0001). CONCLUSIONS: This is the largest study examining costs and dietary patterns of LPDs in patients with PKU and the first study of this kind in other IMD patients requiring an LPD. The study clearly showed that an LPD carries a very high economic burden for families, which may lead to less LPD compliance and potential severe health consequences.
BACKGROUND/ OBJECTIVES:Phenylketonuria (PKU) and several other inherited metabolic diseases (IMD) require a lifelong low-protein diet (LPD), otherwise they lead to many health complications. LPDs, however, carry a significant economic burden for patients and their families. The objective of this study was to explore the costs of low-protein foods (LPFs) necessary for LPD as well as dietary patterns and compliance towards an LPD. SUBJECTS/ METHODS: A detailed questionnaire was created in cooperation with National Association of PKU and other IMD (NSPKU), and consequently sent to all NSPKU members treated with an LPD (n=303). A total of 184 respondents from the Czech Republic were included in the study (174 had PKU, 10 had other IMD). RESULTS: The average daily consumption of LPF was equal to 411.7 g (PKU) and 345.6 g (other IMD), which corresponds to energy value of 5558 kJ and 4438 kJ, respectively, per patient per day. Patients mostly consumed low-protein flour (≈30% of energy intake), pasta (≈18%), basic pastry (≈15%) and sweets (≈10%). The average monthly costs of LPDs were equal to [euro ]130 (PKU) and [euro ]129 (other IMD) per patient per month. The compliance with LPD was decreasing with increasing age (P<0.0001). CONCLUSIONS: This is the largest study examining costs and dietary patterns of LPDs in patients with PKU and the first study of this kind in other IMD patients requiring an LPD. The study clearly showed that an LPD carries a very high economic burden for families, which may lead to less LPD compliance and potential severe health consequences.
Authors: Rianne Jahja; Stephan C J Huijbregts; Leo M J de Sonneville; Jaap J van der Meere; Francjan J van Spronsen Journal: J Pediatr Date: 2014-01-30 Impact factor: 4.406
Authors: K Ahring; A Bélanger-Quintana; K Dokoupil; H Gokmen-Ozel; A M Lammardo; A MacDonald; K Motzfeldt; M Nowacka; M Robert; M van Rijn Journal: Eur J Clin Nutr Date: 2010-12-01 Impact factor: 4.016
Authors: M Bik-Multanowski; B Didycz; R Mozrzymas; M Nowacka; L Kaluzny; W Cichy; B Schneiberg; J Amilkiewicz; A Bilar; M Gizewska; A Lange; E Starostecka; A Chrobot; B I Wojcicka-Bartlomiejczyk; A Milanowski Journal: J Inherit Metab Dis Date: 2008-10-29 Impact factor: 4.982
Authors: Indra Eijgelshoven; Serwet Demirdas; T Alexander Smith; Jeanni M T van Loon; Sabine Latour; Annet M Bosch Journal: Mol Genet Metab Date: 2013-05-10 Impact factor: 4.797
Authors: Matthias R Baumgartner; Friederike Hörster; Carlo Dionisi-Vici; Goknur Haliloglu; Daniela Karall; Kimberly A Chapman; Martina Huemer; Michel Hochuli; Murielle Assoun; Diana Ballhausen; Alberto Burlina; Brian Fowler; Sarah C Grünert; Stephanie Grünewald; Tomas Honzik; Begoña Merinero; Celia Pérez-Cerdá; Sabine Scholl-Bürgi; Flemming Skovby; Frits Wijburg; Anita MacDonald; Diego Martinelli; Jörn Oliver Sass; Vassili Valayannopoulos; Anupam Chakrapani Journal: Orphanet J Rare Dis Date: 2014-09-02 Impact factor: 4.123
Authors: Andrea J Chow; Ryan Iverson; Monica Lamoureux; Kylie Tingley; Isabel Jordan; Nicole Pallone; Maureen Smith; Zobaida Al-Baldawi; Pranesh Chakraborty; Jamie Brehaut; Alicia Chan; Eyal Cohen; Sarah Dyack; Lisa Jane Gillis; Sharan Goobie; Ian D Graham; Cheryl R Greenberg; Jeremy M Grimshaw; Robin Z Hayeems; Shailly Jain-Ghai; Ann Jolly; Sara Khangura; Jennifer J MacKenzie; Nathalie Major; John J Mitchell; Stuart G Nicholls; Amy Pender; Murray Potter; Chitra Prasad; Lisa A Prosser; Andreas Schulze; Komudi Siriwardena; Rebecca Sparkes; Kathy Speechley; Sylvia Stockler; Monica Taljaard; Mari Teitelbaum; Yannis Trakadis; Clara van Karnebeek; Jagdeep S Walia; Brenda J Wilson; Kumanan Wilson; Beth K Potter Journal: BMJ Open Date: 2022-02-22 Impact factor: 2.692
Authors: Friedrich Trefz; Ania C Muntau; Kim M Schneider; Julia Altevers; Christian Jacob; Sebastian Braun; Wolfgang Greiner; Ashok Jha; Mohit Jain; Ignacio Alvarez; Paul Lane; Claudia Zeiss; Frank Rutsch Journal: Mol Genet Metab Rep Date: 2021-05-13